Fingerprint
Dive into the research topics of 'Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1
Manfred Schmitt, Karin Mengele, Rudolf Napieralski, Viktor Magdolen, Ute Reuning, Apostolos Gkazepis, Fred Sweep, Nils Brunner, John Foekens, Nadia Harbeck